192 related articles for article (PubMed ID: 32134153)
1. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition.
Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P
Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153
[TBL] [Abstract][Full Text] [Related]
2. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
[TBL] [Abstract][Full Text] [Related]
3. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
Ren S; Abuel-Haija M; Khurana JS; Zhang X
Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.
Rohilla M; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2015 Oct; 15(5):335-42. PubMed ID: 25700939
[TBL] [Abstract][Full Text] [Related]
6. Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study.
Damiani S; Ludvikova M; Tomasic G; Bianchi S; Gown AM; Eusebi V
Virchows Arch; 1999 Mar; 434(3):227-34. PubMed ID: 10190302
[TBL] [Abstract][Full Text] [Related]
7. Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.
Hua X; Yu L; Huang X; Liao Z; Xian Q
Diagn Pathol; 2011 Nov; 6():111. PubMed ID: 22067528
[TBL] [Abstract][Full Text] [Related]
8. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
9. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast.
Dabbs DJ; Gown AM
Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102
[TBL] [Abstract][Full Text] [Related]
10. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironmental determinants of high-risk DCIS progression.
Borowsky A; Glencer A; Ramalingam K; Schindler N; Mori H; Ghule P; Lee K; Nachmanson D; Officer A; Harismendy O; Stein J; Stein G; Evans M; Weaver D; Yau C; Hirst G; Campbell M; Esserman L
Res Sq; 2024 May; ():. PubMed ID: 38766192
[TBL] [Abstract][Full Text] [Related]
12. CD10-positive myoepithelial cells are usually prominent around in situ lobular neoplasia of the breast and much less prominent or absent in DCIS.
Shousha S; Forbes G; Hopkins I; Wright JA
J Clin Pathol; 2016 Aug; 69(8):702-5. PubMed ID: 26862059
[TBL] [Abstract][Full Text] [Related]
13. Basal cytokeratin phenotypes of myoepithelial cells indicates the origin of ductal carcinomas in situ of the breast.
Chen L; Yin X; Lu S; Chen G; Dong L
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):558-64. PubMed ID: 26336082
[TBL] [Abstract][Full Text] [Related]
14. The Myoepithelial Cells of Salivary Intercalated Duct-type Intraductal Carcinoma Are Neoplastic: A Study Using Combined Whole-slide Imaging, Immunofluorescence, and RET Fluorescence In Situ Hybridization.
Bishop JA; Rooper LM; Sangoi AR; Gagan J; Thompson LDR; Inagaki H
Am J Surg Pathol; 2021 Apr; 45(4):507-515. PubMed ID: 33086236
[TBL] [Abstract][Full Text] [Related]
15. The PD-1/PD-L1 Axis in HER2+ Ductal Carcinoma In Situ (DCIS) of the Breast.
Ubago JM; Blanco LZ; Shen T; Siziopikou KP
Am J Clin Pathol; 2019 Jul; 152(2):169-176. PubMed ID: 30984969
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours.
Łopuszyński W; Szczubiał M; Millán Y; Guil-Luna S; Sánchez-Céspedes R; Martin de Las Mulas J; Śmiech A; Bulak K
Res Vet Sci; 2019 Apr; 123():232-238. PubMed ID: 30685648
[TBL] [Abstract][Full Text] [Related]
17. A METHOD FOR QUANTIFICATION OF CALPONIN EXPRESSION IN MYOEPITHELIAL CELLS IN IMMUNOHISTOCHEMICAL IMAGES OF DUCTAL CARCINOMA IN SITU.
Gray E; Mitchell E; Jindal S; Schedin P; Chang YH
Proc IEEE Int Symp Biomed Imaging; 2018 Apr; 2018():796-799. PubMed ID: 30364524
[TBL] [Abstract][Full Text] [Related]
18. Functional CD3
Lv S; Wang S; Qiao G; Wang X; Zhou X; Yan F; Li Y; Wang S; Morse MA; Hobeika A; Ren J; Lyerly HK
Clin Breast Cancer; 2019 Oct; 19(5):e617-e623. PubMed ID: 31101455
[TBL] [Abstract][Full Text] [Related]
19. Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.
Mack L; Kerkvliet N; Doig G; O'Malley FP
Hum Pathol; 1997 Aug; 28(8):974-9. PubMed ID: 9269835
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
